Fibromyalgia Blood Test UK: The Biomarkers That Rule Out Conditions Mimicking Widespread Pain

1. ESR (Erythrocyte Sedimentation Rate)

ESR measures how quickly red blood cells settle in a test tube over one hour, providing an indirect measure of systemic inflammation. In fibromyalgia investigation, ESR is one of the most important exclusion tests because it helps rule out inflammatory conditions that produce widespread pain — including rheumatoid arthritis, polymyalgia rheumatica, and systemic lupus erythematosus (lupus).

In true fibromyalgia, ESR should be normal. An elevated ESR (above 20 mm/hr in women, above 15 mm/hr in men) raises the possibility of an inflammatory or autoimmune condition. Polymyalgia rheumatica, which causes widespread pain and stiffness predominantly in people over 50, typically produces a markedly elevated ESR (often above 40 mm/hr) and responds dramatically to low-dose prednisolone — a treatment that would be withheld if the condition were misdiagnosed as fibromyalgia.

The NICE CKS on fibromyalgia lists ESR as one of the recommended baseline investigations. ESR is particularly important in people over 50 with new-onset widespread pain, where polymyalgia rheumatica must be excluded.

2. hs-CRP (High-Sensitivity C-Reactive Protein)

CRP is produced by the liver in response to inflammation and rises rapidly (within hours) during acute inflammatory episodes. The high-sensitivity assay (hs-CRP) detects lower levels of inflammation than standard CRP and is useful for identifying chronic low-grade inflammatory states.

In fibromyalgia investigation, CRP serves as a complementary marker to ESR. While ESR is influenced by age, sex, and anaemia, CRP is a more specific marker of acute-phase inflammation. In true fibromyalgia, hs-CRP should be below 3 mg/L. An elevated hs-CRP suggests an inflammatory process — infection, autoimmune disease, or metabolic inflammation — that may be causing or contributing to the pain.

The combination of ESR and CRP together provides a more complete inflammatory picture than either alone. A normal ESR with a normal CRP strongly argues against an inflammatory cause of widespread pain. Both elevated together points firmly towards an inflammatory condition requiring further investigation.

3. TSH (Thyroid-Stimulating Hormone)

Hypothyroidism is the single most important condition to exclude before diagnosing fibromyalgia. The symptom overlap is almost complete: widespread musculoskeletal pain, debilitating fatigue, cognitive dysfunction (“brain fog”), sleep disturbance, depression, and cold sensitivity. An underactive thyroid affects around 2% of the UK population overtly, with subclinical hypothyroidism affecting an additional 5–10%.

TSH is the primary screening test for thyroid dysfunction. An elevated TSH (above 4.0–4.5 mU/L) indicates the thyroid gland is underperforming. Even subclinical hypothyroidism (TSH elevated, FT4 still within range) can produce the full spectrum of fibromyalgia-like symptoms. The NICE CKS on fibromyalgia lists thyroid function tests as a recommended baseline investigation.

The clinical significance cannot be overstated: a person with hypothyroidism does not need fibromyalgia management — they need levothyroxine. Treatment with thyroid replacement hormone typically produces substantial improvement in pain, fatigue, and cognitive function within weeks to months.

4. Free T4 (Thyroxine)

Free T4 is the unbound, biologically active form of the primary thyroid hormone. While TSH is the screening test, FT4 confirms the severity and nature of thyroid dysfunction. A low FT4 with elevated TSH confirms overt hypothyroidism; a normal FT4 with mildly elevated TSH indicates subclinical hypothyroidism.

In fibromyalgia investigation, FT4 is essential because some patients have a TSH at the upper end of the reference range (for example 3.5–4.5 mU/L) with an FT4 at the lower end of its range — a combination that suggests the thyroid is working hard to maintain adequate hormone levels. These borderline patterns can produce widespread pain, fatigue, and cognitive symptoms that meet the clinical criteria for fibromyalgia, even when both values are technically “normal.”

FT4 alongside TSH provides the full thyroid picture needed to confidently exclude thyroid disease. If only TSH is tested and is borderline, the diagnosis of fibromyalgia may be premature without knowing the FT4 level.

5. Ferritin

Ferritin is the primary storage form of iron in the body. Low ferritin indicates depleted iron stores and is a common treatable cause of widespread pain, fatigue, and cognitive dysfunction — the three cardinal features of fibromyalgia. Iron is essential for oxygen transport, energy metabolism, neurotransmitter synthesis (dopamine and serotonin pathways both require iron), and myoglobin function in muscles.

The NHS recognises that iron deficiency causes fatigue, muscle weakness, and cognitive difficulties. A ferritin below 30 μg/L — technically within the NHS “normal” range for women — is associated with significant symptom burden. Many people labelled with fibromyalgia have never had ferritin tested, particularly if their haemoglobin is within the reference range.

Iron deficiency is especially common in women of reproductive age (the same demographic most commonly diagnosed with fibromyalgia). Correcting iron deficiency with supplementation typically produces meaningful improvement in pain, fatigue, and cognition within 4–8 weeks.

6. Full Blood Count (FBC)

The full blood count provides haemoglobin concentration, red cell indices (MCV, MCH, MCHC), white cell count, and platelet count. In fibromyalgia investigation, its primary roles are detecting anaemia (which causes fatigue and widespread pain) and identifying blood count patterns that suggest specific underlying conditions.

Red cell indices help characterise the type of anaemia: microcytic (low MCV) suggests iron deficiency, macrocytic (high MCV) suggests B12 or folate deficiency, and normocytic anaemia may indicate chronic disease, hypothyroidism, or renal causes. White cell abnormalities (particularly lymphopenia) can suggest autoimmune disease, including lupus.

The FBC is one of the baseline investigations recommended by the NICE CKS on fibromyalgia. Even when haemoglobin is within the reference range, a value at the lower end in someone with widespread pain and fatigue warrants investigation of iron stores and B12 levels. The lower boundary of “normal” is not the same as optimal.

7. Vitamin D (25-Hydroxyvitamin D)

Vitamin D deficiency is one of the most commonly missed mimics of fibromyalgia. The overlap is striking: vitamin D deficiency causes widespread musculoskeletal pain, fatigue, muscle weakness, and mood disturbance — a symptom profile essentially identical to fibromyalgia. The SACN 2016 report found that a significant proportion of the UK population has levels below 25 nmol/L in winter.

Multiple studies have found that people diagnosed with fibromyalgia have significantly lower vitamin D levels than healthy controls. A systematic review published in the BMJ found that vitamin D deficiency was more prevalent in people with chronic widespread pain. The NHS vitamin D guidance recognises that deficiency causes bone and muscle pain.

The key clinical question is whether the widespread pain is caused by vitamin D deficiency (and would resolve with supplementation) or whether vitamin D deficiency is coexisting with true fibromyalgia (in which case supplementation would improve but not fully resolve symptoms). The only way to determine this is to correct the deficiency first and reassess. A level below 25 nmol/L demands correction before any fibromyalgia diagnosis can be considered reliable.

8. Vitamin B12

Vitamin B12 deficiency causes neurological symptoms that overlap substantially with fibromyalgia: neuropathic pain, paraesthesiae (tingling and numbness), fatigue, cognitive dysfunction, and mood disturbance. The NHS lists nerve problems such as numbness and tingling, muscle weakness, and psychological problems including depression and cognitive disturbance as symptoms of B12 deficiency.

B12 deficiency is common in the UK, particularly among people over 60, vegetarians and vegans, people taking proton pump inhibitors (PPIs) or metformin, and those with coeliac disease or Crohn's disease. The neuropathic symptoms of B12 deficiency — burning, tingling, shooting pains — can closely mimic the pain patterns described in fibromyalgia.

A B12 below 200 ng/L warrants treatment. Importantly, neurological symptoms from B12 deficiency can become irreversible if left untreated, making early detection critical. If B12 deficiency is identified and treated, the pain, fatigue, and cognitive symptoms may resolve entirely, rendering a fibromyalgia diagnosis unnecessary.

9. HbA1c

HbA1c measures average blood glucose over three months. Its relevance to fibromyalgia investigation operates through two mechanisms. First, pre-diabetes and diabetes cause peripheral neuropathy — nerve damage that produces widespread pain, tingling, and burning sensations that can be mistaken for fibromyalgia. Second, blood sugar dysregulation causes fatigue, cognitive dysfunction, and mood disturbance.

Diabetic neuropathy is the most common form of neuropathy in the UK, and it begins in the pre-diabetic stage (HbA1c 42–47 mmol/mol) before diabetes is formally diagnosed. A person with early neuropathic symptoms from undiagnosed pre-diabetes could easily meet the diagnostic criteria for fibromyalgia — widespread pain, fatigue, and cognitive difficulty — when the actual condition is entirely treatable through lifestyle intervention and, if necessary, medication.

An HbA1c above 48 mmol/mol confirms diabetes. Pre-diabetes (42–47 mmol/mol) affects an estimated 13.6 million adults in England. Identifying this early means the nerve damage can be slowed or prevented, and the symptoms may improve substantially with glycaemic control.

10. ANA (Antinuclear Antibodies)

ANA testing screens for autoimmune connective tissue diseases, particularly systemic lupus erythematosus (lupus) and Sjögren's syndrome. Both conditions cause widespread pain, fatigue, brain fog, and joint symptoms that closely mimic fibromyalgia. Lupus in particular is known as the “great mimicker” because it can affect virtually every organ system.

A positive ANA (typically at a titre of 1:80 or above) does not diagnose lupus on its own — up to 15% of healthy individuals have a low-titre positive ANA. However, a positive ANA in someone with widespread pain, fatigue, and other suggestive features (photosensitivity, oral ulcers, joint swelling, rash, hair loss, Raynaud's phenomenon) warrants urgent rheumatology referral for further investigation including specific antibodies (anti-dsDNA, anti-Ro, anti-La, anti-Sm, complement levels).

The importance of ANA testing in fibromyalgia investigation is that lupus and Sjögren's syndrome require fundamentally different treatment — immunosuppression rather than pain management. Missing an autoimmune diagnosis by labelling someone with fibromyalgia can delay appropriate treatment by years and allow irreversible organ damage.

1. Hypothyroidism

Hypothyroidism is the fibromyalgia mimic that clinicians most frequently emphasise. The NHS describes hypothyroidism as causing tiredness, weight gain, muscle aches and weakness, depression, poor memory, and sensitivity to cold — a symptom profile that overlaps almost entirely with fibromyalgia. Both conditions disproportionately affect women.

The blood test pattern is: elevated TSH (above 4.5 mU/L) with low or low-normal FT4. In subclinical hypothyroidism, TSH is elevated but FT4 remains within the reference range. The mechanism involves reduced cellular energy production throughout the body, impaired neurotransmitter metabolism, and accumulation of glycosaminoglycans in soft tissues causing widespread aching.

Treatment with levothyroxine typically produces substantial improvement in pain, fatigue, and cognitive function. Studies suggest that 30–40% of people initially diagnosed with fibromyalgia who are subsequently found to have thyroid dysfunction experience significant symptom improvement or complete resolution with thyroid treatment alone.

2. Iron Deficiency

Iron deficiency is one of the most common nutritional deficiencies worldwide and a leading treatable cause of widespread pain, fatigue, and cognitive dysfunction. The NHS estimates that around 3 million people in the UK have iron deficiency. Symptoms occur both with frank anaemia and with iron depletion alone (low ferritin, normal haemoglobin).

The blood test pattern is: low ferritin (below 30 μg/L), sometimes accompanied by low haemoglobin and low MCV (microcytic anaemia). Iron is required for myoglobin function in muscles (explaining widespread muscle pain), cerebral oxygen delivery (explaining brain fog), and dopamine and serotonin synthesis (explaining mood disturbance and pain amplification).

Iron repletion with oral supplementation typically produces improvement in fatigue and pain within 4–8 weeks, though full iron store repletion takes 3–6 months. The cause of iron deficiency should always be identified — heavy menstrual bleeding, coeliac disease, and gastrointestinal bleeding are the most common causes in the UK.

3. Vitamin D Deficiency

Vitamin D deficiency (below 50 nmol/L) affects an estimated one in five UK adults and is even more prevalent in winter. The symptom overlap with fibromyalgia is extensive: widespread musculoskeletal pain, proximal muscle weakness, fatigue, and mood disturbance. A systematic review and meta-analysis found that people with fibromyalgia had significantly lower vitamin D levels than healthy controls.

The blood test pattern is: 25-hydroxyvitamin D below 50 nmol/L. Severe deficiency (below 25 nmol/L) is associated with the highest symptom burden. Vitamin D deficiency causes pain through multiple mechanisms: osteomalacia (softening of bone), myopathy (muscle weakness), and pro-inflammatory effects (vitamin D normally suppresses TNF-alpha and IL-6).

Supplementation with vitamin D to achieve levels above 75 nmol/L has shown benefit in reducing pain scores in several randomised controlled trials of people with chronic widespread pain. The SACN 2016 report recommends supplementation at 400 IU daily for the general population, with higher doses considered safe for correcting deficiency.

4. Autoimmune Disease — Lupus, Sjögren's, and Rheumatoid Arthritis

Autoimmune connective tissue diseases are among the most important conditions to exclude before diagnosing fibromyalgia. Systemic lupus erythematosus (lupus) causes widespread pain, fatigue, brain fog, and joint symptoms that can be indistinguishable from fibromyalgia in the early stages. Sjögren's syndrome causes fatigue, widespread pain, and neuropathy alongside its hallmark dryness symptoms. Early rheumatoid arthritis can present with diffuse pain before obvious joint swelling develops.

The blood test pattern is: positive ANA (titre 1:80 or above), elevated ESR, and elevated CRP. A positive ANA does not confirm autoimmune disease on its own, but it warrants further investigation with specific antibodies. For lupus, anti-dsDNA and complement levels are key. For Sjögren's, anti-Ro (SS-A) and anti-La (SS-B) antibodies. For rheumatoid arthritis, RF and anti-CCP antibodies.

The significance of excluding autoimmune disease is fundamental: these conditions require immunosuppressive treatment that would never be offered under a fibromyalgia diagnosis. Delay in diagnosis of lupus allows cumulative organ damage including nephritis (kidney inflammation) that can become irreversible.

5. Vitamin B12 Deficiency

B12 deficiency causes a distinctive pattern of neurological symptoms that can mimic fibromyalgia: neuropathic pain (burning, tingling, shooting pains), fatigue, cognitive dysfunction (“brain fog”), and mood disturbance. The NHS lists nerve problems, muscle weakness, and psychological difficulties as recognised symptoms of B12 deficiency.

The blood test pattern is: low B12 (below 200 ng/L), often with raised MCV (macrocytic) on FBC. Neurological symptoms from B12 deficiency can occur even before anaemia develops, which means a normal haemoglobin does not exclude B12 deficiency as a cause of pain and neurological symptoms.

Treatment depends on the cause. Pernicious anaemia requires lifelong intramuscular B12 injections. Dietary deficiency can be treated with oral supplements (1,000–2,000 μg daily). Importantly, B12 deficiency neuropathy can become permanent if untreated, making early detection essential — a delay caused by attributing the symptoms to fibromyalgia can result in irreversible nerve damage.

1. Graded Exercise Therapy

Graded exercise therapy (GET) is recommended by the NICE CKS on fibromyalgia and EULAR 2017 guidelines as a first-line intervention with Level 1 evidence. The approach involves starting at a low, tolerable baseline of activity and gradually increasing duration and intensity over weeks to months.

A Cochrane systematic review of exercise for fibromyalgia found that aerobic exercise reduces pain, improves physical function, and reduces fatigue. The key principle is consistency rather than intensity — moderate aerobic exercise (walking, swimming, cycling) performed 2–3 times per week has the strongest evidence. The initial increase in symptoms that some people experience when starting exercise typically resolves within 2–4 weeks if the grading is appropriate. A physiotherapist experienced in chronic pain can help design an individualised programme.

2. CBT for Pain Management

Cognitive behavioural therapy for chronic pain management is recommended by NICE and EULAR as a first-line non-pharmacological intervention for fibromyalgia. CBT does not claim that the pain is “all in your head” — it addresses the cognitive and behavioural patterns that amplify pain perception and disability.

A meta-analysis of CBT for fibromyalgia published in the BMJ found significant improvements in pain, fatigue, depression, and disability. CBT helps by addressing pain catastrophising, fear-avoidance behaviour, sleep disruption, and activity pacing. In the UK, CBT for chronic pain is available through IAPT (Improving Access to Psychological Therapies) services, though waiting times vary considerably.

3. Vitamin D Repletion (If Deficient)

Where vitamin D deficiency is confirmed (below 50 nmol/L), supplementation to achieve levels above 75 nmol/L has shown benefit in reducing pain scores in people with fibromyalgia in several randomised controlled trials. The SACN 2016 report recommends 400 IU daily for the general population, with higher doses (up to 4,000 IU daily) considered safe for correcting deficiency.

Even in confirmed fibromyalgia (where vitamin D deficiency is a coexisting condition rather than the primary cause), correcting vitamin D to optimal levels reduces the overall symptom burden. Vitamin D3 (cholecalciferol) is more effective than D2 (ergocalciferol) at raising and maintaining serum levels.

4. Iron Repletion (If Ferritin Low)

Where iron deficiency is confirmed (ferritin below 30 μg/L), iron supplementation addresses a modifiable contributor to pain and fatigue. The NHS recommends oral ferrous sulphate as first-line treatment, with treatment continuing for three months after normalisation to replete stores.

Iron repletion to ferritin above 50 μg/L is associated with improved energy, reduced muscle pain, and better cognitive function. Oral iron should be taken on an empty stomach with vitamin C to improve absorption. Taking iron every other day, which recent evidence suggests produces equivalent repletion with fewer side effects, can help manage gastrointestinal symptoms.

5. Thyroid Treatment (If Hypothyroid)

Where hypothyroidism is confirmed (elevated TSH with low or low-normal FT4), levothyroxine treatment is essential. This is not an “intervention for fibromyalgia” — it is treatment for the underlying condition that was causing the symptoms. However, it is listed here because many people with a fibromyalgia label are subsequently found to have thyroid dysfunction, and treatment can be transformative.

The NHS hypothyroidism guidance outlines the standard treatment pathway. Your GP will typically start levothyroxine at a low dose and titrate upwards based on TSH levels. Full symptom improvement may take several months as thyroid levels stabilise.

6. Pharmacological Options

Your GP may consider pharmacological treatment for fibromyalgia where non-pharmacological interventions are insufficient. The NICE CKS on fibromyalgia and EULAR 2017 guidelines identify low-dose amitriptyline (10–50 mg at night) and duloxetine (60 mg daily) as the pharmacological options with the best evidence base. These address pain, sleep disturbance, and mood simultaneously.

It is important to note that standard painkillers (paracetamol, ibuprofen, codeine) are generally ineffective for fibromyalgia pain and are not recommended. Opioids are explicitly recommended against by both NICE and EULAR due to lack of efficacy and risk of dependence. Gabapentinoids (pregabalin) may be considered by specialists but are second-line. Any pharmacological treatment should be discussed with and prescribed by your GP or specialist — this guide does not recommend specific medications.

7. Sleep Hygiene

Poor sleep is both a cause and a consequence of fibromyalgia. Unrefreshing sleep is one of the diagnostic criteria, and sleep disruption amplifies pain perception through central sensitisation. Improving sleep quality is therefore both a symptom management strategy and a treatment for the underlying pain mechanism.

Evidence-based sleep hygiene for fibromyalgia includes: maintaining a consistent sleep-wake schedule (including weekends), keeping the bedroom cool and dark, avoiding screens for one hour before bed, limiting caffeine after midday, and avoiding alcohol as a sleep aid (it disrupts sleep architecture). CBT for insomnia (CBT-I) has the strongest evidence for improving sleep in fibromyalgia and is available through some NHS services. Your GP may also consider low-dose amitriptyline at night, which improves sleep quality as one of its primary mechanisms of action.

Can a blood test diagnose fibromyalgia?

No. There is no blood test that confirms fibromyalgia. Fibromyalgia is a diagnosis of exclusion — blood tests are used to rule out other conditions that cause similar symptoms (hypothyroidism, iron deficiency, vitamin D deficiency, autoimmune disease, diabetes). When all exclusion tests are normal and the symptom pattern fits (widespread pain for more than three months, fatigue, cognitive disturbance, unrefreshing sleep), fibromyalgia can be diagnosed with confidence using the ACR 2010/2016 criteria.

What blood tests should I ask my GP for if I suspect fibromyalgia?

As a minimum, ask for a full blood count, ESR, CRP, thyroid function (TSH and free T4), ferritin, and vitamin D. If autoimmune disease is a possibility, add ANA. Vitamin B12 and HbA1c complete the exclusion panel. The NICE CKS on fibromyalgia recommends baseline blood tests to exclude other conditions before making the diagnosis. If your GP has only tested FBC and inflammatory markers, the exclusion is incomplete.

Can fibromyalgia cause abnormal blood test results?

True fibromyalgia should not cause abnormal blood test results. By definition, fibromyalgia is a condition where standard blood tests are normal. If your blood tests show abnormalities — elevated inflammatory markers, abnormal thyroid function, low ferritin, low vitamin D, positive ANA — these suggest another condition is present that needs to be investigated and treated. Fibromyalgia can coexist with other conditions, but the other condition should be addressed first.

Is fibromyalgia an autoimmune condition?

Fibromyalgia is not currently classified as an autoimmune condition. It is classified as a central sensitisation syndrome — a condition where the central nervous system amplifies pain signals. However, emerging research suggests immune system involvement, and fibromyalgia frequently coexists with autoimmune conditions including lupus, Sjögren’s syndrome, and rheumatoid arthritis. ANA testing is important to ensure that an autoimmune condition is not being misdiagnosed as fibromyalgia.

How long does fibromyalgia diagnosis take in the UK?

The average time from first symptoms to fibromyalgia diagnosis in the UK is over four years, according to patient surveys. This delay often reflects incomplete exclusion testing, multiple referrals, and the absence of a confirmatory diagnostic test. Having a comprehensive blood panel done early in the investigation process can significantly shorten this timeline by quickly ruling out treatable mimics and allowing the diagnosis to be made with confidence.

Can vitamin D deficiency cause fibromyalgia-like symptoms?

Yes. Vitamin D deficiency causes widespread musculoskeletal pain, fatigue, muscle weakness, and mood disturbance — a symptom profile that closely mimics fibromyalgia. Studies have found that people with fibromyalgia have significantly lower vitamin D levels than healthy controls. A level below 25 nmol/L (severe deficiency) should be corrected before a fibromyalgia diagnosis is considered reliable. If symptoms resolve with vitamin D supplementation, the diagnosis was likely vitamin D deficiency rather than fibromyalgia.

Will my GP accept private blood test results for fibromyalgia investigation?

Most GPs will review private blood test results and use them to inform clinical decisions. UKAS-accredited private labs, which Helvy uses, meet the same quality standards as NHS laboratories. Present your results clearly, explain your symptom history, and ask specifically about any abnormal values. Some GPs may wish to repeat a confirmatory test through their own lab before initiating treatment, particularly for thyroid function or ANA.